Tatva Chintan Pharma Chem Limited - Asset Resilience Ratio

Latest as of September 2025: 0.58%

Tatva Chintan Pharma Chem Limited (TATVA) has an Asset Resilience Ratio of 0.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Rs53.09 Million
≈ $574.15K USD Cash + Short-term Investments

Total Assets

Rs9.08 Billion
≈ $98.17 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2025)

This chart shows how Tatva Chintan Pharma Chem Limited's Asset Resilience Ratio has changed over time. Check how strategically is Tatva Chintan Pharma Chem Limited's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tatva Chintan Pharma Chem Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tatva Chintan Pharma Chem Limited market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs0.00 0%
Short-term Investments Rs53.09 Million 0.58%
Total Liquid Assets Rs53.09 Million 0.58%

Asset Resilience Insights

  • Limited Liquidity: Tatva Chintan Pharma Chem Limited maintains only 0.58% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Tatva Chintan Pharma Chem Limited Industry Peers by Asset Resilience Ratio

Compare Tatva Chintan Pharma Chem Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cngr Advanced Material Co Ltd
SHE:300919
Specialty Chemicals 0.52%
Luxi Chemical Group Co Ltd
SHE:000830
Specialty Chemicals 0.43%
Guangdong HongDa Blasting Co Ltd
SHE:002683
Specialty Chemicals 1.05%
Lily Group Co Ltd
SHG:603823
Specialty Chemicals 0.37%
Lianhe Chemical Technology Co Ltd
SHE:002250
Specialty Chemicals 0.44%
Shandong Link Science and Technology Co Ltd
SHE:001207
Specialty Chemicals 18.99%
Shenzhen WOTE Advanced Materials Co Ltd
SHE:002886
Specialty Chemicals 3.77%
New East New Materials Co Ltd
SHG:603110
Specialty Chemicals 6.08%

Annual Asset Resilience Ratio for Tatva Chintan Pharma Chem Limited (2018–2025)

The table below shows the annual Asset Resilience Ratio data for Tatva Chintan Pharma Chem Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.04% Rs3.27 Million
≈ $35.36K
Rs8.36 Billion
≈ $90.44 Million
-1.23pp
2024-03-31 1.27% Rs103.64 Million
≈ $1.12 Million
Rs8.19 Billion
≈ $88.54 Million
-0.57pp
2023-03-31 1.83% Rs138.50 Million
≈ $1.50 Million
Rs7.56 Billion
≈ $81.79 Million
+1.71pp
2022-03-31 0.12% Rs8.02 Million
≈ $86.73K
Rs6.58 Billion
≈ $71.19 Million
-0.15pp
2021-03-31 0.27% Rs8.43 Million
≈ $91.17K
Rs3.15 Billion
≈ $34.04 Million
-0.17pp
2020-03-31 0.44% Rs10.92 Million
≈ $118.10K
Rs2.49 Billion
≈ $26.92 Million
-4.12pp
2019-03-31 4.55% Rs85.40 Million
≈ $923.57K
Rs1.88 Billion
≈ $20.28 Million
+3.63pp
2018-03-31 0.93% Rs13.38 Million
≈ $144.70K
Rs1.44 Billion
≈ $15.62 Million
--
pp = percentage points

About Tatva Chintan Pharma Chem Limited

NSE:TATVA India Specialty Chemicals
Market Cap
$448.02 Million
Rs41.43 Billion INR
Market Cap Rank
#12670 Global
#640 in India
Share Price
Rs1771.00
Change (1 day)
-0.96%
52-Week Range
Rs982.10 - Rs1800.10
All Time High
Rs2866.25
About

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and br… Read more